Both in Biotechnology
BioStem Technologies vs Acumen Pharmaceuticals
Over the past year BSEM returned −73.3% and ABOS returned −92.6%; their daily moves had a correlation of 0.24.
BSEM −73.3% ABOS −92.6%Growth of $1, one year, split-adjusted
| Metric | BSEM | ABOS |
|---|---|---|
| Price | $1.15 | $0.2163 |
| Market cap | $21.5M | $15.6M |
| Today | 0.00% | −7.72% |
| 1 month | −53.4% | −89.3% |
| 6 months | — | −91.6% |
| Year to date | — | −89.7% |
| 1 year | — | −90.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $52.3M |
| Dividend yield | — | — |
| Volatility (60d) | — | 492.9% |
| Short % of float | 2.3% | 7.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).